Home/Filings/4/0001562180-19-003623
4//SEC Filing

GARDNER JASON 4

Accession 0001562180-19-003623

CIK 0001690585other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:02 PM ET

Size

8.3 KB

Accession

0001562180-19-003623

Insider Transaction Report

Form 4
Period: 2019-06-20
GARDNER JASON
DirectorSee Remarks
Transactions
  • Sale

    Common Stock

    2019-06-20$15.10/sh1,669$25,202361,543 total
  • Sale

    Common Stock

    2019-06-21$15.11/sh12,331$186,321349,212 total
Holdings
  • Common Stock

    (indirect: By Trust)
    292,990
  • Common Stock

    (indirect: By Trust)
    359,092
Footnotes (2)
  • [F1]This trade is pursuant to an active 10b5-1 plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $15.10 to $15.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001741286

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:02 PM ET
Size
8.3 KB